Industry

Largest study to-date of corneal cross-linking to treat keratoconus Company aims to develop leading standard of care for keratoconus and corneal ectasia SHERBORN, Mass.–(BUSINESS WIRE)–CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase 2 study for keratoconus in Cornea: The Journal of Cornea and … [Read more…]

Agilent will fund STEM students from underrepresented groups, and provide lab instrumentation and mentorship to support postgraduate research in the life sciences SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) is launching a partnership with Delaware State University (DSU), a leading historically Black university, to increase the share of underrepresented students entering STEM fields, a … [Read more…]

First-of-its-kind system enables a new class of solid-state thermal management systems that is currently only possible with bulkier, mechanical alternatives PASADENA, Calif.–(BUSINESS WIRE)–DTP Thermoelectrics has been awarded a patent that opens the door for solid-state deep cooling thermal management. The patent is based on theoretical and analytical models that have been validated through the fabrication … [Read more…]

Thursday, October 13, 2022, 6:00 -7:00 PM EDT; Cambridge, MA, USA A look at the benefits and challenges of decentralized clinical trials and the implications for their long-term adoption CAMBRIDGE, Mass.–(BUSINESS WIRE)–Join PROMETRIKA and guest Ken Getz, MBA, Executive Director of the Tufts Center for the Study of Drug Development, to explore the ongoing experience … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Air Treatment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis By Type and Application” report has been added to ResearchAndMarkets.com’s offering. The air treatment market in Asia Pacific is expected to grow from US$1,964.85 million in 2021 to US$2,822.13 million by 2028; it is estimated to register a CAGR … [Read more…]

— Immune responses observed in endometrial cancer and glioblastoma models, complementing prior clinical success in glioblastoma and supporting further development of IEC-001 for the treatment of endometrial cancer — — Data further elucidates foundational anti-tumor mechanisms of the company’s immunotherapeutic platform — PHILADELPHIA–(BUSINESS WIRE)–Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, is … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Patient At Home Testing Kits Market, By Test Type, By Sample, By Usage, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Saudi Arabia patient at home testing kits market is anticipated to grow at a robust CAGR in the forecast period, 2023-2027. … [Read more…]

For the first half of 2022 turnover was €0.5 million and cash and cash equivalents were €38.4 million as of June 30, 2022 Significant milestones achieved in clinical and cGMP manufacturing programs over first half of 2022: Initiation of pivotal open-label, single-arm, Phase 3 trial of MaaT013 in acute Graft-vs-host-Disease in Europe in Q1 2022 … [Read more…]

EWING, N.J.–(BUSINESS WIRE)–Church & Dwight Co., Inc. (NYSE: CHD) will host a conference call to discuss third quarter 2022 earnings results on October 28, 2022, at 10:00 a.m. ET. Media and investors may access the live audio webcast at www.churchdwight.com beginning at 10:00 a.m. ET. The webcast will also be available for replay. Church & … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Australia Regenerative Medicine Market, By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Australia regenerative medicine market is projected to grow at a significant CAGR during the forecast period, 2023-2027. The market growth can be attributed to the expanding healthcare infrastructure … [Read more…]